Concepedia
Statistics
Publications
22
Citations
1.1K
H-Index
19
Active since
1989
Affiliations
Ipsen (France)(Current)
Laboratoire de Biologie Cellulaire et Moléculaire du Contrôle de la Prolifération
Centre National de la Recherche Scientifique
Université Toulouse III - Paul Sabatier
Inserm
Olivier Lavergne is an author at Ipsen (France) specializing in pharmacology, chemotherapy, and cancer pharmacology.
Publications per year
1989–2009
Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
Olivier Lavergne, Laurence Lesueur‐Ginot, Francesc Pla Rodas et al. · Journal of Medicinal Chemistry · 1998 · 151 citations
Medicine, Medicinal Chemistry, Pharmacology +13
Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.
Laurence Lesueur‐Ginot, Danièle Demarquay, Róbert Kiss et al. · PubMed · 1999 · 109 citations
Medicine, Medicinal Chemistry, Pharmacology +12
BN 80245: An E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activities
Olivier Lavergne, Laurence Lesueur‐Ginot, Francesc Pla Rodas et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 97 citations
Pharmacy, Medicinal Chemistry, Pharmacology +10
Inhibition of Heterotrimeric G Protein Signaling by a Small Molecule Acting on Gα Subunit
Mohammed Akli Ayoub, Marjorie Damian, Christian Gespach et al. · Journal of Biological Chemistry · 2009 · 75 citations · Full text
Life Sciences, Biochemistry, Pharmacology +17
Topoisomerase I-Mediated Antiproliferative Activity of Enantiomerically Pure Fluorinated Homocamptothecins
Olivier Lavergne, Danièle Demarquay, Christian Bailly et al. · Journal of Medicinal Chemistry · 2000 · 70 citations
Medicine, Medicinal Chemistry, Pharmacology +14
1–5 of 22